306 results on '"Astegiano, M"'
Search Results
2. Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy
3. Letter: therapeutic drug monitoring and inflammatory bowel disease—a call for an urgent standardization of the results
4. Letter: biologics treatment in Crohnʼs disease and risk of bowel resection—what about the patients who stop anti‐TNF therapy?
5. P301 Non-familial small bowel carcinomas in Crohnʼs disease: clinico-pathological, molecular and prognostic features
6. P178 Validation of the clinical utility of IFI16-based markers in IBD
7. The mesenteric flap: a technique for pelvic closure after proctectomy for Crohnʼs disease
8. Efficacy and safety of oral beclomethasone dipropionate for ileal or ileal-right colon Crohn's disease of mild-to-moderate activity or in remission: Retrospective study
9. A preserved stratified pattern of the bowel wall 1 year after major surgery does not influence the surgical recurrence of Crohn’s disease
10. Activity of Crohn disease: value of Color-Power-Doppler and contrast-enhanced ultrasonography
11. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference
12. H2-breath testing for carbohydrate malabsorption
13. Antibodies toMycobacterium paratuberculosis in patients with Crohn's disease
14. Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis
15. T.03.3 FECAL SMALL NON-CODING RNAS AND MICROBIOME CHARACTERIZE PATIENTS WITH CELIAC DISEASE
16. CHRONIC HEPATITIS DUE TO HCV, MIXED CRYOGLOBULINEMIA AND CARPAL TUNNEL SYNDROME: A CASE-CONTROL STUDY
17. Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis
18. Controlled trial of oral 5-aminosalicylic acid for the prevention of early relapse in Crohn's disease
19. OC.09.2 VITAMIN D-RELATED GENETICS AS PREDICTOR OF RESPONSE TO ADALIMUMAB IN CROHN’S DISEASE
20. Detection of anti- Saccharomyces cerevisiae antibodies in Crohn's disease: is it reliable diagnostic and prognostic marker?
21. Clinical features in familial cases of Crohn’s disease and ulcerative colitis in Italy: a GISC study
22. T04.01.5 RELATIONSHIP BETWEEN ADALIMUMAB, PHARMACOKINETICS AND VITAMIN D-RELATED MARKERS
23. T04.01.4 USE OF ADALIMUMAB BIOSIMILAR ABP 501 IN CROHN'S DISEASE: AN OBSERVATIONAL STUDY
24. OC.12.6 PREVALENCE OF ANAEMIA IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS OF THE OBSERVATIONAL ITALIAN MULTICENTRE IG-IBD STUDY RIDART 1
25. OC.10.6 THE MOST INAPPROPRIATELY PRESCRIBED GASTROINTESTINAL DRUGS ON THE TERRITORY IN THE OVER-75S
26. P.02.12 PREDICTIVE VALUE OF THE “DICA” ENDOSCOPIC CLASSIFICATION ON THE OUTCOME OF DIVERTICULAR DISEASE OF THE COLON: A 1-YEAR ANALYSIS FROM THE INTERNATIONAL, MULTICENTER, PROSPECTIVE STUDY
27. OC.03.3 THE “DICA” ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE OF THE COLON SHOWS A SIGNIFICANT INTEROBSERVER AGREEMENT AMONG COMMUNITY ENDOSCOPISTS
28. PC.01.4 PREVALENCE OF ANAEMIA IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS OF THE OBSERVATIONAL ITALIAN MULTICENTRE IG-IBD STUDY RIDART 1
29. OC.11.1 PROGRAMMED CELL DEATH LIGAND-1 (PD-L1) EXPRESSION IS COUPLED WITH MICROSATELLITE INSTABILITY IN NON-FAMILIAL SMALL BOWEL CARCINOMAS ASSOCIATED OR NOT WITH COELIAC DISEASE OR CROHN'S DISEASE: RESULTS FROM THE SMALL BOWEL CANCER ITALIAN CONSORTIUM
30. OC.12.4 PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE: ANALYSIS OF INTESTINAL OUTCOME AFTER LIVER TRANSPLANTATION
31. P.11.17: The Role of Adherence to Therapy on the Outcome in Inflammatory Bowel Disease
32. OC.14.7: The Role of Anti-IFI16 Antibodies in the Management of Inflammatory Bowel Diseases (IBD)
33. OC.10.4: Survival of Non-Familial Small Bowel Carcinomas Depends on the Underlying Intestinal Immune-Mediated Disorder
34. P.06.2 HOW MUCH DO CELIAC PATIENTS KNOW ABOUT GLUTEN FREE DIET?
35. OC.11.2 CROHN'S DISEASE-ASSOCIATED SMALL BOWEL CARCINOMAS SHOW DISTINCTIVE HISTOLOGY AND PHENOTYPE IN COMPARISON TO SPORADIC CASES: AN ITALIAN MULTICENTRE STUDY
36. Abdominal pain and bowel dysfunction: diagnostic role of intestinal ultrasound.
37. P.04.8 ROLE OF BACTERIAL OVERGROWTH IN CROHN'S DISEASE PATIENTS WITH ILEOCOLIC RESECTION: GLUCOSE BREATH TEST EVALUATION
38. OC.11.4 LONG TERM EFFICACY OF GRANULOCYTE-MONOCYTE-APHERESIS IN ULCERATIVE COLITIS. THE ITALIAN REGISTRY OF THERAPEUTIC APHERESIS
39. OC.05.5 DEVELOPMENT AND VALIDATION OF AN ENDOSCOPIC CLASSIFICATION OF DIVERTICULAR DISEASE OF THE COLON: THE DICA CLASSIFICATION
40. P424 Long term efficacy of granulocyte-monocyte-apheresis in ulcerative colitis. The Italian Registry of Therapeutic Apheresis
41. P.4.17 LABORATORY TESTS IN COMPLICATED COELIAC PATIENTS VS. COELIAC CONTROLS
42. P.03.10 INOSINE TRIPHOSPHATE PYROPHOSPHATASE 94 C>A POLYMORPHISM IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS TREATED WITH THIOPURINE
43. P.02.22 FECAL CALPROTECTIN IS AN EFFECTIVE DIAGNOSTIC TOOL THAT DIFFERENTIATES PATHOLOGICAL FROM FUNCTIONAL INTESTINAL DISORDERS
44. P.02.18 POWER DOPPLER SONOGRAPHY TO PREDICT THE RISK OF POST-SURGICAL RECURRENCE IN CROHN'S DISEASE
45. P.02.7 EVALUATION OF TPMT GENOTYPE IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL DISEASE (IBD) TREATED WITH THIOPURINE
46. Inflammatory bowel diseases and primary sclerosing cholangitis: hepatic and pancreatic side effects due to azathioprine.
47. Internet use among inflammatory bowel disease patients: an Italian multicenter survey.
48. Methodology and Indications of H2-Breath Testing in Gastrointestinal Diseases: the Rome Consensus Conference.
49. P.11.19 EVALUATION OF BONE METABOLISM AT DIAGNOSIS OF CELIAC DISEASE AND DURING FOLLOW-UP
50. P.11.11 HELICOBACTER PYLORI IN CELIAC DISEASE AND IN DUODENAL INTRAEPITHELIAL LYMPHOCYTOSIS: A RETROSPECTIVE STUDY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.